It's not uncommon for companies to transition to defensive plays as established market share, economic moats and slowing end-market growth discourages its new entrants. What's more, there's nothing wrong with defensive companies - they can enjoy solid margins and cash flows, and they often pay healthy (and reliable) dividends.

It's not so common, however, to see defensive companies aggressively seek to become more offensive. This transition not only creates a large amount of execution risk, it also demands capital that more conservative investors usually prefer to see directed towards dividends and buybacks. Nevertheless, Ecolab (NYSE:ECL) continues to push on with an acquisition program that has meaningfully altered its business mix and given it greater long-term growth potential.

Forex Broker Guide: Using the right broker is essential when competing in today's forex marketplace.

Buying a Champion in Energy
The first thing most investors think when hearing the name Ecolab is probably "cleaning and sanitation," and, indeed, Ecolab remains a very large player when it comes to cleaning and sanitation products, as well as services for the hospitality sector (as well as healthcare, food/beverage and other sectors).

Less appreciated has been Ecolab's sizable energy sector specialty chemicals business, a business that is the number two player in the sector behind Baker Hughes (NYSE:BHI). Now, however, the company is looking to become much larger with the $2.2 billion deal for privately-held Champion Technologies. With this deal, Ecolab will become the number one player in the segment, 50% larger than Baker Hughes and substantially larger than Schlumberger (NYSE:SLB) and Multi-Chem.

Champion is presently the number three player in this segment, with a much greater focus on upstream (95% of the business) than Ecolab's current business. Not only will this deal build on Ecolab's water treatment capabilities (increasingly important in oil/gas production), but it also adds products like hydrate inhibitors and sour corrosion inhibitors. All in all, given that these chemicals are increasingly important for improving yields, prolonging equipment life and reducing environmental damage, this looks like a solid growth investment for Ecolab.

SEE: What Makes An M&A Deal Work?

A Deal that Requires Some Management Skill
Ecolab is not exactly getting Champion for a song. The company is paying about $2.2 billion, with 75% of it in cash ($1.7 billion) and the remainder in shares (a collared deal that required about 8 million shares at the time of announcement). That works out to more than 11 times 2012 EBITDA, though Ecolab management believes that deal synergies should push that down to about 9 times EBITDA. Whether an investor looks at other energy service companies or specialty chemical companies, that's still on the high end of the valuation range.

Champion seems to have below-peer operating margins today, and that's where Ecolab management's skills come into play. This business should fit in well with Ecolab's existing operations, and Ecolab has done pretty well with the margins of its existing energy business, so management's forecasts for synergies and value accretion have some credibility. Nevertheless, with this deal levering up the business further and expanding its non-defensive exposure, those margin improvements will be critical in adding long-term value.

SEE: Analyzing Operating Margins

The Bottom Line
Ecolab remains a compelling company in many respects. Although it competes with some large players such as General Electric (NYSE:GE), Ashland (NYSE:ASH) and ISS A/S in markets like water treatment and sanitation, it enjoys solid market positions, good margins and returns, and solid (if somewhat inconsistent) free cash flow margins.

Now the company is taking on some additional risk in the pursuit of better growth. With global oil and gas production unlikely to decline any time soon, this deal for Champion should be a good compliment to its more stable operations. The company's debt level is going to be a little high after this deal, but patient dividend-motivated investors should find something to like in the company's greater long-term potential to grow dividends after this deal.

At the time of writing, Stephen D. Simpson did not own any shares in any company mentioned in this article.

Related Articles
  1. Stock Analysis

    How Toyota Succeeds at Home and Abroad (TM)

    Japan's biggest car manufacturer is also one of North America's biggest, delighting shareholders with its high profit margins.
  2. Stock Analysis

    Starbucks: Profiting One Cup at a Time (SBUX)

    Starbucks is everywhere. But is it a worthwhile business? Ask the shareholders who've made it one of the world's most successful companies.
  3. Stock Analysis

    How Medtronic Makes Money (MDT)

    Here's the story of an American medical device firm that covers almost every segment in medicine and recently moved to Ireland to pay less in taxes.
  4. Investing News

    Latest Labor Numbers: Good News for the Market?

    Some economic numbers are indicating that the labor market is outperforming the stock market. Should investors be bullish?
  5. Investing News

    Stocks with Big Dividend Yields: 'It's a Trap!'

    Should you seek high yielding-dividend stocks in the current investment environment?
  6. Investing News

    Should You Be Betting with Buffett Right Now?

    Following Warren Buffett's stock picks has historically been a good strategy. Is considering his biggest holdings in 2016 a good idea?
  7. Products and Investments

    Cash vs. Stocks: How to Decide Which is Best

    Is it better to keep your money in cash or is a down market a good time to buy stocks at a lower cost?
  8. Investing News

    Who Does Cheap Oil Benefit? See This Stock (DG)

    Cheap oil won't benefit most companies, but this retailer might buck that trend.
  9. Investing

    How to Ballast a Portfolio with Bonds

    If January and early February performance is any guide, there’s a new normal in financial markets today: Heightened volatility.
  10. Stock Analysis

    Performance Review: Emerging Markets Equities in 2015

    Find out why emerging markets struggled in 2015 and why a half-decade long trend of poor returns is proving optimistic growth investors wrong.
RELATED FAQS
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>
COMPANIES IN THIS ARTICLE
Trading Center